SEARCH

SEARCH BY CITATION

Reference

  • Alander, M., Satokari, R., Korpela, R., Saxelin, M., Vilpponen-Salmela, T., Mattila-Sandholm, T., and von Wright, A. (1999) Persistence of colonization of human colonic mucosa by a probiotic strain, Lactobacillus rhamnosus GG, after oral consumption. Appl Environ Microbiol 65: 351354.
  • Andoh, A., Fujiyama, Y., Sakumoto, H., Uchihara, H., Kimura, T., Koyama, S., and Bamba, T. (1998) Detection of complement C3 and factor B gene expression in normal colorectal mucosa, adenomas and carcinomas. Clin Exp Immunol 111: 477483.
  • van Baarlen, P., Troost, F.J., van Hemert, S., van der Meer, C., de Vos, W.M., de Groot, P.J., et al. (2009) Differential NF-kappa B pathways induction by Lactobacillus plantarum in the duodenum of healthy humans correlating with immune tolerance. Proc Natl Acad Sci USA 106: 23712376.
  • Boesten, R.J., and de Vos, W.M. (2008) Interactomics in the human intestine –Lactobacilli and Bifidobacteria make a difference. J Clin Gastroenterol 42: S163S167.
  • Claesson, M.J., van Sinderen, D., and O'Toole, P.W. (2007) The genus Lactobacillus – a genomic basis for understanding its diversity. FEMS Microbiol Lett 269: 2228.
  • Comstock, L.E., and Kasper, D.L. (2006) Bacterial glycans: key mediators of diverse host immune responses. Cell 126: 847850.
  • Coyne, M.J., Chatzidaki, M., Paoletti, L., and Comstock, L.E. (2008) Role of glycan synthesis in colonization of the mammalian gut by the bacterial symbiont Bacteroides fragilis. Proc Natl Acad Sci USA 105: 1309913104.
  • Dann, S.M., and Eckmann, L. (2007) Innate immune defenses in the intestinal tract. Curr Opin Gastroenterol 23: 115120.
  • De Keersmaecker, S.C.J., Braeken, K., Verhoeven, T.L.A., Perea Vélez, M., Lebeer, S., Vanderleyden, J., and Hols, P. (2006) Flow cytometric testing of green fluorescent protein-tagged Lactobacillus rhamnosus GG for response to defensins. Appl Environ Microbiol 72: 49234930.
  • Di Caro, S., Tab, H., Grillo, A., Elia, C., Gasbarrini, G., Sepulveda, A.R., and Gasbarrini, A. (2005) Effects of Lactobacillus GG on genes expression pattern in small bowel mucosa. Dig Liver Dis 37: 320329.
  • Doron, S., Snydman, D.R., and Gorbach, S.L. (2005) Lactobacillus GG: bacteriology and clinical applications. Gastroenterol Clin North Am 34: 483498.
  • Fletcher, C.M., Coyne, M.J., Bentley, D.L., Villa, O.F., and Comstock, L.E. (2007) Phase-variable expression of a family of glycoproteins imparts a dynamic surface to a symbiont in its human intestinal ecosystem. Proc Natl Acad Sci USA 104: 24132418.
  • Francius, G., Lebeer, S., Alsteens, D., Wildling, L., Gruber, H.J., Hols, P., et al. (2008) Detection, localization and conformational analysis of single polysaccharide molecules on live bacteria. ACS Nano 2: 19211929.
  • Gorbach, S.L. (1996) The discovery of Lactobacillus GG. Nutr Today 31: 2S5S.
  • Gorbach, S.L., Chang, T.W., and Goldin, B. (1987) Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG. Lancet 2: 1519.
  • Gryllos, I., Tran-Winkler, H.J., Cheng, M.F., Chung, H., Bolcome, R., 3th, Lu, W., et al. (2008) Induction of group A Streptococcus virulence by a human antimicrobial peptide. Proc Natl Acad Sci USA 105: 1675516760.
  • Guandalini, S., Pensabene, L., Zikri, M.A., Dias, J.A., Casali, L.J., Hoekstra, H., et al. (2000) Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. J Pediatr Gastroenterol Nutr 30: 5460.
  • Hooper, L.V., and Gordon, J.I. (2001) Glycans as legislators of host–microbial interactions: spanning the spectrum from symbiosis to pathogenicity. Glycobiology 11: 1R10R.
  • Kalliomäki, M., Salminen, S., Arvilommi, H., Kero, P., Koskinen, P., and Isolauri, E. (2001) Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357: 10761079.
  • Kalliomäki, M., Salminen, S., Poussa, T., Arvilommi, H., and Isolauri, E. (2003) Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 361: 18691871.
  • Kankainen, M., Paulin, L., Tynkkynen, S., von Ossowski, I., Reunanen, J., Partanen, P., et al. (2009) Comparative genomic analysis of Lactobacillus rhamnosus GG reveals pili containing a human-mucus binding protein. Proc Natl Acad Sci USA 106: 1719317198.
  • Klaenhammer, T.R., Barrangou, R., Buck, B.L., Azcarate-Peril, M.A., and Altermann, E. (2005) Genomic features of lactic acid bacteria effecting bioprocessing and health. FEMS Microbiol Rev 29: 393409.
  • Kleerebezem, M., Hols, P., Bernard, E., Rolain, T., Zhou, M.M., Siezen, R.J., and Bron, P.A. (2010) The extracellular biology of the lactobacilli. FEMS Microbiol Rev 34: 199230.
  • Landersjö, C., Yang, Z.N., Huttunen, E., and Widmalm, G. (2002) Structural studies of the exopolysaccharide produced by Lactobacillus rhamnosus strain GG (ATCC 53103). Biomacromolecules 3: 880884.
  • Lebeer, S., Verhoeven, T.L.A., Perea Vélez, M., Vanderleyden, J., and De Keersmaecker, S.C.J. (2007) Impact of environmental and genetic factors on biofilm formation by the probiotic strain Lactobacillus rhamnosus GG. Appl Environ Microbiol 73: 67686775.
  • Lebeer, S., Vanderleyden, J., and De Keersmaecker, S. (2008a) Genes and molecules of Lactobacillus supporting probiotic action. Microbiol Mol Biol Rev 72: 728764.
  • Lebeer, S., Claes, I.J.J., Verhoeven, T.L.A., Shen, C., Lambrichts, I., Ceuppens, J.L., et al. (2008b) Impact of luxS and suppressor mutations on the gastrointestinal transit of Lactobacillus rhamnosus GG. Appl Environ Microbiol 74: 47114718.
  • Lebeer, S., Verhoeven, T.L.A., Francius, G., Schoofs, G., Lambrichts, I., Dufrene, Y.F., et al. (2009) Identification of a gene cluster for the biosynthesis of a long galactose-rich exopolysaccharide in Lactobacillus rhamnosus GG and functional analysis of the priming glycosyltransferase. Appl Environ Microbiol 75: 35543563.
  • Lerouge, I., and Vanderleyden, J. (2002) O-antigen structural variation: mechanisms and possible roles in animal/plant–microbe interactions. FEMS Microbiol Rev 26: 1747.
  • Limura, M., Gallo, R.L., Hase, K., Miyamoto, Y., Eckmann, L., and Kagnoff, M.F. (2005) Cathelicidin mediates innate intestinal defense against colonization with epithelial adherent bacterial pathogens. J Immunol 174: 49014907.
  • Liu, C.H., Lee, S.M., VanLare, J.M., Kasper, D.L., and Mazmanian, S.K. (2008) Regulation of surface architecture by symbiotic bacteria mediates host colonization. Proc Natl Acad Sci USA 105: 39513956.
  • Magee, A.D., and Yother, J. (2001) Requirement for capsule in colonization by Streptococcus pneumoniae. Infect Immun 69: 37553761.
  • Makarova, K., Slesarev, A., Wolf, Y., Sorokin, A., Mirkin, B., Koonin, E., et al. (2006) Comparative genomics of the lactic acid bacteria. Proc Natl Acad Sci USA 103: 1561115616.
  • Marco, M.L., Pavan, S., and Kleerebezem, M. (2006) Towards understanding molecular modes of probiotic action. Curr Opin Biotechnol 17: 204210.
  • Perea Vélez, M., Verhoeven, T.L.A., Draing, C., Von Aulock, S., Pfitzenmaier, M., Geyer, A., et al. (2007) Functional analysis of d-alanylation of lipoteichoic acid in the probiotic strain Lactobacillus rhamnosus GG. Appl Environ Microbiol 73: 35953604.
  • Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY, USA: Cold Spring Harbor Laboratory.
  • Sanders, M.E. (2008) Probiotics: definition, sources, selection, and uses. Clin Infect Dis 46: S58S61.
  • Schneider, J.J., Unholzer, A., Schaller, M., Schafer-Korting, M., and Korting, H.C. (2005) Human defensins. J Mol Med 83: 587595.
  • Tuomola, E., Crittenden, R., Playne, M., Isolauri, E., and Salminen, S. (2001) Quality assurance criteria for probiotic bacteria. Am J Clin Nutr 73: 393S398S.
  • Vanderhoof, J.A., Whitney, D.B., Antonson, D.L., Hanner, T.L., Lupo, J.V., and Young, R.J. (1999) Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatr 135: 564568.
  • Weidenmaier, C., Kristian, S.A., and Peschel, A. (2003) Bacterial resistance to antimicrobial host defenses – an emerging target for novel antiinfective strategies? Curr Drug Targets 4: 643649.
  • Zipfel, P.F., and Skerka, C. (2009) Complement regulators and inhibitory proteins. Nat Rev Immunol 9: 729740.